Detalhe da pesquisa
1.
First-line nivolumab plus ipilimumab versus chemotherapy in patients with unresectable malignant pleural mesothelioma: 3-year outcomes from CheckMate 743.
Ann Oncol
; 33(5): 488-499, 2022 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-35124183
2.
Malignant pleural mesothelioma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-upâ.
Ann Oncol
; 33(2): 129-142, 2022 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-34861373
3.
Maintenance bevacizumab-pemetrexed after first-line cisplatin-pemetrexed-bevacizumab for advanced nonsquamous nonsmall-cell lung cancer: updated survival analysis of the AVAPERL (MO22089) randomized phase III trial.
Ann Oncol
; 25(5): 1044-52, 2014 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-24585722
4.
[The French mesothelioma network from 1998 to 2013]. / Mésothéliome: les dispositifs en place en France « le réseau mésothéliome ¼ 1998-2013.
Ann Pathol
; 34(1): 51-63, 2014 Feb.
Artigo
em Francês
| MEDLINE | ID: mdl-24630637
5.
Surrogate markers predicting overall survival for lung cancer: ELCWP recommendations.
Eur Respir J
; 39(1): 9-28, 2012 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-21737547
6.
Malignant pleural mesothelioma: from the bench to the bedside.
Respiration
; 83(6): 481-93, 2012.
Artigo
em Inglês
| MEDLINE | ID: mdl-22710421
7.
Prophylactic radiotherapy to prevent procedure-tract metastases.
Lancet Oncol
; 17(10): e417, 2016 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-27733263
8.
Valproate-doxorubicin: promising therapy for progressing mesothelioma. A phase II study.
Eur Respir J
; 37(1): 129-35, 2011 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-20530048
9.
Validation and comparison of several published prognostic systems for patients with small cell lung cancer.
Eur Respir J
; 38(3): 657-63, 2011 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-21622585
10.
First-line nivolumab plus ipilimumab with two cycles of chemotherapy versus chemotherapy alone (four cycles) in advanced non-small-cell lung cancer: CheckMate 9LA 2-year update.
ESMO Open
; 6(5): 100273, 2021 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-34607285
11.
Inter- and intraobserver consistency in assessing eligibility for bevacizumab (BVZ) in non-small-cell lung cancer (NSCLC) patients with centrally located tumors.
Ann Oncol
; 21(8): 1682-1686, 2010 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-20064831
12.
Guidelines of the European Respiratory Society and the European Society of Thoracic Surgeons for the management of malignant pleural mesothelioma.
Eur Respir J
; 35(3): 479-95, 2010 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-19717482
13.
Treatment of malignant pleural mesothelioma: current status and future directions.
Monaldi Arch Chest Dis
; 73(2): 79-85, 2010 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-20949774
14.
Clinical utility of diagnostic markers for malignant pleural mesothelioma.
Monaldi Arch Chest Dis
; 71(1): 31-8, 2009 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-19522163
15.
A phase III randomised study of concomitant induction radiochemotherapy testing two modalities of radiosensitisation by cisplatin (standard versus daily) for limited small-cell lung cancer.
Ann Oncol
; 19(10): 1691-7, 2008 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-18504252
16.
[Other thoracic cancers. Malignant pleural mesothelioma: biology and diagnosis]. / Mésothéliome pleural malin: biologie et diagnostic.
Rev Mal Respir
; 25(8 Pt 2): 3S183-90, 2008 Oct.
Artigo
em Francês
| MEDLINE | ID: mdl-18971844
17.
[Anti-tumor immunotherapy in malignant pleural mesothelioma]. / Immunothérapie anti-tumorale dans le mésothéliome pleural malin.
Rev Mal Respir
; 35(4): 465-476, 2018 Apr.
Artigo
em Francês
| MEDLINE | ID: mdl-29415822
18.
New Insights on Diagnostic Reproducibility of Biphasic Mesotheliomas: A Multi-Institutional Evaluation by the International Mesothelioma Panel From the MESOPATH Reference Center.
J Thorac Oncol
; 13(8): 1189-1203, 2018 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-29723687
19.
[Pleural mesothelioma: impact of the staging for the therapeutic strategy]. / Mésothéliome pleural : conséquences de la stadification sur la stratégie thérapeutique.
Rev Mal Respir
; 24(8 Pt 2): 6S146-56, 2007 Oct.
Artigo
em Francês
| MEDLINE | ID: mdl-18235408
20.
Diagnosis of primary antibody and complement deficiencies in young adults after a first invasive bacterial infection.
Clin Microbiol Infect
; 23(8): 576.e1-576.e5, 2017 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-28192236